研究業績

2024年研究業績

Yamaguchi H, Matsumura T, Sugawa H, Niimi N, Sango K, Nagai R. Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes. J Biol Chem, 2024 Jun 13:107479.
Niimi N, Sango K. Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy. J Diabetes Investig, 15:817-819 (2024)
Ishiguro H, Ushiki T, Honda A, Yoshimatsu Y, Ohashi R, Okuda S, Kawasaki A, Cho K, Tamura S, Suwabe T, Katagiri T, Ling Y, Iijima A, Mikami T, Kitagawa H, Uemura A, Sango K, Masuko M, Igarashi M, Sone H. Reduced chondroitin sulfate content prevents diabetic neuropathy through transforming growth factor-β signaling suppression. iScience, 27, 109528 (2024)
Nihei W, Kato A, Himeno T, Kondo M, Nakamura J, Kamiya H, Sango K, Kato K. Hyperglycaemia aggravates oxidised low-density lipoprotein-induced Schwann cell death via hyperactivation of Toll-like receptor 4. Neurol Int 16, 370-379 (2024)
Japanese Peripheral Nerve Society. Abstracts of the 34th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS). J Peripher Nerv Syst 29, S1-S19 (2024)